Journal Information
Vol. 27. Issue. S5.October 2007
Pages 1-67
Full text access
¿El tratamiento con espironolactona incrementa el efecto de IECAS y ARAII en el control de la proteinuria y la progresión de la insuficiencia renal en pacientes con ERC?
Does therapy with spironolactone increase the effect of ACEIs and ARA-II for managing proteinuria and renal failure progression in patients with chronic renal disease?
Visits
13342
A. Ramos, C. Caramelo
This item has received
Download PDF
Idiomas
Nefrología (English Edition)
Article options
Tools